Telix Pharmaceuticals (ASX:TLX) received notice that its Chief Executive Christian Behrenbruch sold 2 million shares in the company at AU$29.50 per share by way of a block trade, according to a Thursday Australian bourse filing.
Behrenbruch now holds shares equal to about 6.3% of the company's issued capital and has no intention to sell them, the filing said.
Additionally, the company's co-founder Andreas Kluge sold 2 million shares in the company for the same price.
Company shares were down nearly 2% in recent Thursday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.